PD-L1 and CD8+PD1+lymphocytes Exist as Targets in the Pediatric Tumor Microenvironment for Immunomodulatory Therapy

OncoImmunology - United States
doi 10.1080/2162402x.2015.1029701
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Understanding the Role of PD-L1/PD1 Pathway Blockade and Autophagy in Cancer Therapy

OncoTargets and Therapy
OncologyPharmacology
2017English

The Tumor Suppressor miR-138-5p Targets PD-L1 in Colorectal Cancer

Oncotarget
Oncology
2016English

Tumor Microenvironment as the “Regulator” and “Target” for Gene Therapy

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Tumor Stroma as Targets for Cancer Therapy

Pharmacology and Therapeutics
Pharmacology
2013English

Molecular Machineries of pH Dysregulation in Tumor Microenvironment: Potential Targets for Cancer Therapy

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2017English

Targeting the PD1/PD-L1 Axis in Melanoma: Biological Rationale, Clinical Challenges and Opportunities

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2014English

104 CD8+CD69+CD103+/- T Cells in the Tumor Microenvironment and in the Skin of Memory-Conditioned Mice Are Expanded by Anti-Pd1

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy